Impact BioMedical Inc. (IBO)
0.44
-0.07 (-13.73%)
At close: Apr 16, 2025, 3:59 PM
0.42
-2.97%
After-hours: Apr 16, 2025, 07:57 PM EDT
-13.73% (1D)
| Bid | 0.41 |
| Market Cap | 5.04M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.71K |
| EPS (ttm) | -2.3 |
| PE Ratio (ttm) | -0.19 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.47 |
| Volume | 641,545 |
| Avg. Volume (20D) | 6,166,313 |
| Open | 0.47 |
| Previous Close | 0.51 |
| Day's Range | 0.42 - 0.47 |
| 52-Week Range | 0.37 - 6.17 |
| Beta | 7.31 |
About IBO
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory an...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 2
Stock Exchange AMEX
Ticker Symbol IBO
Website https://www.impactbiomedinc.com
6 months ago
+19.2%
Impact BioMedical shares are trading higher after ...
Unlock content with
Pro Subscription